Formulation of Medicated Chewing Gum Containing Sceletium tortuosum and Process Optimization Utilizing the SeDeM Diagram Expert System
- PMID: 33712901
- DOI: 10.1208/s12249-021-01961-8
Formulation of Medicated Chewing Gum Containing Sceletium tortuosum and Process Optimization Utilizing the SeDeM Diagram Expert System
Abstract
Sceletium tortuosum is one of the most promising medicinal plant species for treating anxiety and depression. Traditionally, aerial parts are chewed (masticatory herbal medicine) providing fast relief and rendering the masticatory route for delivery, ideal. This study intended formulating novel medicated chewing gum containing S. tortuosum to alleviate depression and anxiety. S. tortuosum extract was formulated into directly compressed medicated chewing gum (MCG) containing different Health-in-Gum® (HIG) bases through process optimization with the SeDeM Diagram Expert System. Physical properties of MCGs were characterized, and specialized drug release studies performed. According to the manufacturer, only HIG-03 was specifically developed for direct compression; however, the SeDeM System was successfully applied to all HIG-bases investigated. HIG-01 and HIG-04 are also considered useful in direct compression as no considerable differences in these MCG formulations' physical properties were recognized. Inclusion of a lubricant, however, is deemed essential, and MCG comprising HIG-01, most suited for direct compression. Dissolution experiments found only two alkaloids used as markers, mesembrine and mesembrenone, were released in quantifiable concentrations regardless formulation constituents. Novel directly compressed MCG-containing S. tortuosum extract was successfully formulated by which the biologically active phytochemicals of S. tortuosum can be scientifically delivered through the traditionally applied mastication method.
Keywords: Health-in-Gum®; Sceletium tortuosum; SeDeM Diagram Expert System; direct compression; medicated chewing gum.
References
-
- Welz N, Emberger-Klein A, Menrad K. Why people use herbal medicine: insights from a focus-group study in Germany. BMC Complement Altern Med. 2018;18(92). https://doi.org/10.1186/s12906-018-2160-6 .
-
- Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:1663–9812. https://doi.org/10.3389/fphar.2013.00177 . - DOI
-
- WHO. National policy on traditional medicine and regulation of herbal medicines. Report of a WHO global survey.; 2019 January 15. https://apps.who.int/medicinedocs/en/d/Js7916e/6.html . Accessed 18 March 2020.
-
- Bennett AC, van Camp A, López V, Smith C. Sceletium tortuosum may delay chronic disease progression via alkaloid-dependent antioxidant or anti-inflammatory action. J Physiol Biochem. 2018;74:539–47. https://doi.org/10.1007/s13105-018-0620-6 . - DOI - PubMed
-
- Gericke N. Kabbo’s! Kwaiń: The past, present and possible future of kanna. In: McKenna D, Prance GT, Davis W, De Leonen B, editors. The ethnopharmacological search for psychoactive drugs. Santa Fe: Synergetic Press; 2018. p. 122–50.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
